Molecular basis of insulin resistance, E. Clauser, et al; insulin-induced and constitutive internalization of the insulin receptor, J.L. Carpentier; assessment of insulin resistance in vivo - application to the study of type 2 diabetes, A.J. Scheen and P.J. Lefebvre; the syndrome of insulin resistance, P. Vague and D. Raccah; hyperinsulinemia, insulin resistance and essential hypertension, P. Passa; hypertriglyceridemia - cause or consequence of insulin resistance?, F. Berthezene; insulin resistance and polycystic ovarian syndrome, D. Dewailly, et al; age-related insulin resistance - a review; Vialettes, B. et al; pharmacological approach in the treatment of insulin resistance, P. Silvestre; the thyroid hormone receptors - molecular basis of thyroid hormone resistance, P. De Nayer; thyroid hormone generalized resistance, C. Jaffiol, et al; pituitary resistance to thyroid hormones, P. Beck-Peccoz, et al; differential initiation of translation of a single estrogen receptor mRNA could explain some estradiol resistance cases, C. Toulas, et al; D2 dopaminergic receptors - normal and abnormal transduction mechanisms, L. Caccavelli, et al; prolactinomas and resistance to dopamine agonists, T. Brue, et al; G-protein oncogenes in acromegaly, A. Spada and L. Vallar; resistance to somatostatin (SRIH) analog therapy in acromegaly - re-evaluation of the correlation between the SRIH receptor status of the pituitary tumour and the in vivo inhibition of GH secretion in response to SRIH analog, J. Bertherat, et al; autocrine and paracrine effects of peptides on human pituitary cells, D. Joubert, et al.
